{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:11:21Z","timestamp":1795169481400,"version":"4.10.3"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Uniting Innovation Grant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.drugpo.2019.01.026","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T01:32:04Z","timestamp":1554773524000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia\u2019s responses to opioid misuse?"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1334-5425","authenticated-orcid":false,"given":"Vendula","family":"Belackova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-8449","authenticated-orcid":false,"given":"Allison M.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Jauncey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2019.01.026_bib0005","series-title":"National opioid pharmacotherapy statistics","author":"AIHW","year":"2014"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0010","series-title":"National opioid pharmacotherapy statistics 2015","author":"AIHW","year":"2016"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0015","series-title":"Alcohol and other drug treatment services in Australia 2015\u201316","author":"AIHW","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0020","series-title":"National drug strategy household survey 2016: Detailed findings (9781760541941)","author":"AIHW","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1360-0443.1993.tb02053.x","article-title":"Should the controlled provision of heroin be a treatment option? Australia feasibility consideration","volume":"88","author":"Bammer","year":"1993","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.drugpo.2019.01.026_bib0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5694\/j.1326-5377.1996.tb122243.x","article-title":"The ACT heroin trial proposal: An overview","volume":"164","author":"Bammer","year":"1996","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0035","series-title":"Report into the feasibility of trialling hydromorphone as a treatment for heroin dependence in the australian capital territory","author":"Bammer","year":"2004"},{"issue":"7","key":"10.1016\/j.drugpo.2019.01.026_bib0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/add.14171","article-title":"Cost-effectiveness of hydromorphone for severe opioid use disorder: Findings from the SALOME randomized clinical trial","volume":"113","author":"Bansback","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0045","series-title":"Guidance for injectable opioid agonist treatment for opioid use disorder","author":"BCCS","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0050","first-page":"520","article-title":"Politics, practice, and research into treatment of heroin addiction","volume":"Vol. 1","author":"Bell","year":"2009"},{"issue":"7","key":"10.1016\/j.drugpo.2019.01.026_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0706743716673966","article-title":"Supervised injectable heroin: A clinical perspective","volume":"62","author":"Bell","year":"2016","journal-title":"The Canadian Journal of Psychiatry"},{"issue":"13","key":"10.1016\/j.drugpo.2019.01.026_bib0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40265-018-0962-y","article-title":"Supervised injectable opioid treatment (SIOT) for the management of opioid dependence","volume":"78","author":"Bell","year":"2018","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.026_bib0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1360-0443.2009.02754.x","article-title":"Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands","volume":"105","author":"Blanken","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7517-10-6","article-title":"Yet they failed to do so: Recommendations based on the experiences of NAOMI research survivors and a call for action","volume":"10","author":"Boyd","year":"2013","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-017-0152-3","article-title":"Telling our stories: Heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver","volume":"14","author":"Boyd","year":"2017","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.026_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/dar.12209","article-title":"Senior nurses\u2019 perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy","volume":"34","author":"Bui","year":"2015","journal-title":"Drug and Alcohol Review"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.026_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","article-title":"Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction","volume":"203","author":"Byford","year":"2013","journal-title":"The British Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/10345329.1998.12036112","article-title":"Trial by media: Politics, policy and public opinion, the case of the ACT heroin trial","volume":"10","author":"Christie","year":"1998","journal-title":"Current Issues in Criminal Justice"},{"issue":"6","key":"10.1016\/j.drugpo.2019.01.026_bib0095","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.drugpo.2013.07.004","article-title":"Shouting through bullet-proof glass: Some reflections on pharmacotherapy provision in one Australian clinic","volume":"24","author":"Crawford","year":"2013","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0100","series-title":"BC coroners service death review panel: A review of ilicit drug overdose","author":"CSDRP","year":"2018"},{"issue":"7","key":"10.1016\/j.drugpo.2019.01.026_bib0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1360-0443.2005.01094.x","article-title":"Effects of a sustained heroin shortage in three Australian States","volume":"100","author":"Degenhardt","year":"2005","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugpo.2019.01.026_bib0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000369337","article-title":"Efficacy of heroin-assisted treatment in Belgium: A randomised controlled trial","volume":"21","author":"Demaret","year":"2015","journal-title":"European Addiction Research"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsat.2016.06.005","article-title":"Loss of treatment benefit when heroin-assisted treatment is stopped after 12 months","volume":"69","author":"Demaret","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.drugpo.2019.01.026_bib0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1360-0443.2004.00654.x","article-title":"Serious adverse events in the Australian national evaluation of pharmacotherapies for opioid dependence (NEPOD)","volume":"99","author":"Digiusto","year":"2004","journal-title":"Addiction"},{"issue":"7503","key":"10.1016\/j.drugpo.2019.01.026_bib0125","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","article-title":"Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials","volume":"330","author":"Dijkgraaf","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0130","series-title":"NDARC monograph, 27","article-title":"Tha national drug strategy: The first 10 years and beyond","author":"Dillon","year":"1995"},{"issue":"8","key":"10.1016\/j.drugpo.2019.01.026_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003410.pub3","article-title":"Heroin maintenance for chronic heroin-dependent individuals","author":"Ferri","year":"2010","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugpo.2018.12.006","article-title":"\u201cIt\u2019s about bloody time\u201d: Perceptions of people who use drugs regarding drug law reform","volume":"64","author":"Greer","year":"2019","journal-title":"The International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence","volume":"191","author":"Haasen","year":"2007","journal-title":"The British Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.026_bib0150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1360-0443.2004.00717.x","article-title":"The contribution of research to Australian policy responses to heroin dependence 1990\u20132001: A personal retrospection","volume":"99","author":"Hall","year":"2004","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.026_bib0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5694\/j.1326-5377.2002.tb04289.x","article-title":"Breaking the deadlock over an Australian trial of injectable opioid maintenance","volume":"176","author":"Hall","year":"2002","journal-title":"The Medical Journal of Australia"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.026_bib0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10361140701319986","article-title":"John Howard\u2019s \u2018values\u2019 and Australian identity","volume":"42","author":"Johnson","year":"2007","journal-title":"Australian Journal of Political Science"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0165","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annual Review of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0170","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12889-017-4785-7","article-title":"Estimating the number of people who inject drugs in Australia","volume":"17","author":"Larney","year":"2017","journal-title":"BMC Public Health"},{"issue":"30","key":"10.1016\/j.drugpo.2019.01.026_bib0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1467-842X.2000.tb01565.x","article-title":"Senting the wrong signal\": Analysis of print media reportage of the ACT heroin prescription trial proposal, August 1997","volume":"24","author":"Lawrence","year":"2000","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"14","key":"10.1016\/j.drugpo.2019.01.026_bib0180","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.drugpo.2019.01.026_bib0185","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1360-0443.2008.02260.x","article-title":"Future challenges for heroin and other opioid substitution treatment","volume":"103","author":"Lintzeris","year":"2008","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2019.01.026_bib0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00023210-200923060-00002","article-title":"Prescription of heroin for the management of heroin dependence","volume":"23","author":"Lintzeris","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction","volume":"31","author":"March","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.drugpo.2019.01.026_bib0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1176\/appi.ps.53.8.984","article-title":"The gap between research and practice in substance abuse treatment","volume":"53","author":"Marinelli-Casey","year":"2002","journal-title":"Psychiatric Services"},{"issue":"9719","key":"10.1016\/j.drugpo.2019.01.026_bib0205","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.026_bib0210","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.026_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.apnr.2018.12.003","article-title":"Exploring the experiences of staff working at an opiate assisted treatment clinic: An interpretive descriptive study","volume":"45","author":"McCall","year":"2018","journal-title":"Applied Nursing Research"},{"issue":"12","key":"10.1016\/j.drugpo.2019.01.026_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/15265161.2017.1388870","article-title":"Risk environments and the ethics of reducing drug-related harms","volume":"17","author":"McGowan","year":"2017","journal-title":"The American Journal of Bioethics"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0230","series-title":"Serious shortage of methadone programs","author":"McNamara","year":"2012"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0235","series-title":"A deadly drug being passed off as MDMA and heroin has hit Australian shores, authorities have warned","author":"McVeigh","year":"2017"},{"issue":"12","key":"10.1016\/j.drugpo.2019.01.026_bib0240","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5694\/j.1326-5377.1998.tb141444.x","article-title":"Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions","volume":"168","author":"Metrebian","year":"1998","journal-title":"The Medical Journal of Australia"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2006.03.005","article-title":"Disseminating evidence-based practices in substance abuse treatment: A review with suggestions","volume":"31","author":"Miller","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0250","series-title":"Proceedings of a seminar held on 1 November 1991","article-title":"Heroin treatment\u2014New alternatives","author":"NCEPH","year":"1991"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.03.057","article-title":"Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin","volume":"189","author":"Neale","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2019.01.026_bib0260","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1503\/cmaj.110669","article-title":"Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment","volume":"184","author":"Nosyk","year":"2012","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0265","series-title":"NSW clinical guidelines: Treatment of opioid dependence","author":"NSW Health","year":"2018"},{"issue":"8","key":"10.1016\/j.drugpo.2019.01.026_bib0270","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1747-597X-9-23","article-title":"Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment","volume":"9","author":"Oviedo-Joekes","year":"2014","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.026_bib0280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: A randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2017.02.021","article-title":"Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder","volume":"176","author":"Oviedo-Joekes","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2019.01.026_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jsat.2010.03.003","article-title":"Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: A pilot study","volume":"38","author":"Oviedo-Joekes","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1465-3362.2009.00100.x","article-title":"The Andalusian trial on heroin-assisted treatment: A 2 year follow-up","volume":"29","author":"Oviedo-Joekes","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"7150","key":"10.1016\/j.drugpo.2019.01.026_bib0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0305","series-title":"Polygon: The many sides to the Australian opioid pharmacotherapy maintenance system","author":"Ritter","year":"2009"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0310","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2147\/DDDT.S72543","article-title":"Advances in the delivery of buprenorphine for opioid dependence","volume":"11","author":"Rosenthal","year":"2017","journal-title":"Drug Design, Development and Therapy"},{"issue":"12","key":"10.1016\/j.drugpo.2019.01.026_bib0315","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: Randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0320","article-title":"Fees for pharmacotherapy: An unfair burden","volume":"Vol. 9","author":"Rossmanith","year":"2011"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0325","series-title":"Accidental drug-induced deaths due to opioids in Australia, 2013","author":"Roxburgh","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0330","article-title":"Beyond a safe injection: What are the health and social needs of clients of a supervised injecting facility?","author":"Salmon","year":"2018","journal-title":"Paper presented at the APSAD"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.026_bib0335","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/add.13539","article-title":"Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: Realizing its potential","volume":"112","author":"Sigmon","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0340","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09687637.2013.793892","article-title":"How can and do empirical studies influence drug policies? Narratives and complexity in the use of evidence in policy making","volume":"20","author":"Stevens","year":"2013","journal-title":"Drugs Education Prevention & Policy"},{"issue":"9729","key":"10.1016\/j.drugpo.2019.01.026_bib0350","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomised trial","volume":"375","author":"Strang","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2019.01.026_bib0355","series-title":"Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond","author":"Strang","year":"2012"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.026_bib0360","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction","volume":"207","author":"Strang","year":"2015","journal-title":"The British Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.026_bib0365","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0376-8716(03)00013-9","article-title":"Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia","volume":"70","author":"Topp","year":"2003","journal-title":"Drug & Alcohol Dependence"},{"issue":"7410","key":"10.1016\/j.drugpo.2019.01.026_bib0370","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials","volume":"327","author":"Van den Brink","year":"2003","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.drugpo.2019.01.026_bib0375","article-title":"Serious shortage of methadone programs","author":"Wodak","year":"2012","journal-title":"Medical Journal of Australia (MJA Insight)"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:45:13Z","timestamp":1760629513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919300945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":75,"alternative-id":["S0955395919300945"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.026","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia\u2019s responses to opioid misuse?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}